Pham Thi Huyen Thoa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pham Thi Huyen Thoa has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Dinh Quang Khieu
Hue University
3 shared publications - Nguyen Quang Man
University of Medicine and Pharmacy, Hue University, Vietnam
3 shared publications - Bao Chi Nguyen
Department of Science, Technology & International Relations, Hue University
2 shared publications - Le Lam Son
University of Sciences, Hue University, Hue City, Vietnam
2 shared publications - Le Van Thanh Son
University of Education and Science, The University of Danang, Danang City, Vietnam
2 shared publications - Tu Quy Phan
Department of Science and Technology, Tay Nguyen University, Dak Lak, Vietnam
2 shared publications
Latest Publications
- Open Access
- 15 August 2026
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14
Simultaneous electrochemical determination of acetaminophen and ciprofloxacin in pharmaceutical formulations using a holmium-modified UiO-66 metal-organic framework electrode
Background and purpose: The simultaneous determination of acetaminophen (ACE) and ciprofloxacin (CIP) is of considerable importance for pharmaceutical quality control, necessitating the development of sensitive and reliable electrochemical sensors. In this study, a holmium-modified UiO-66 metal-organic framework (Ho/UiO-66) was synthesized and evaluated as an electrode modifier for the simultaneous electrochemical determination of ACE and CIP. Experimental approach: Ho/UiO-66 was synthesized via a solvothermal method and characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, Raman spectroscopy, nitrogen adsorption-desorption analysis, scanning electron microscopy, transmission electron microscopy and energy-dispersive X-ray mapping. The electrochemical behaviour of ACE and CIP at the Ho/UiO-66-modified glassy carbon electrode (Ho/UiO-66/GCE) was investigated using cyclic voltammetry and differential pulse voltammetry. The effects of solution pH, scan rate, accumulation potential, and accumulation time were systematically optimized. Key results: The characterization results demonstrated the successful incorporation of Ho species while preserving the crystalline structure of UiO-66. Among the investigated materials, Ho/UiO-66 (3/100 molar ratio) exhibited the most favourable combination of crystallinity, porosity and electrochemical performance, and was therefore selected for sensor fabrication. Under the optimized conditions, well-resolved oxidation peaks for ACE and CIP were obtained, enabling their simultaneous determination without mutual interference. The oxidation processes were found to be predominantly diffusion-controlled. The developed sensor exhibited satisfactory analytical performance with wide linear concentration ranges, low detection limits, satisfactory repeatability, reproducibility, and long-term stability. The sensor was applied to the determination of ACE and CIP in real pharmaceutical samples with satisfactory recoveries. The analytical results showed good agreement with those obtained using the reference high-performance liquid chromatography method. Conclusion: The proposed Ho/UiO-66/GCE sensor provides a reliable and practical platform for the simultaneous electrochemical determination of ACE and CIP, demonstrating its potential applicability for pharmaceutical analysis.
- 15 August 2026
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14
Open AccessSimultaneous electrochemical determination of acetaminophen and ciprofloxacin in pharmaceutical formulations using a holmium-modified UiO-66 metal-organic framework electrode
Background and purpose: The simultaneous determination of acetaminophen (ACE) and ciprofloxacin (CIP) is of considerable importance for pharmaceutical quality control, necessitating the development of sensitive and reliable electrochemical sensors. In this study, a holmium-modified UiO-66 metal-organic framework (Ho/UiO-66) was synthesized and evaluated as an electrode modifier for the simultaneous electrochemical determination of ACE and CIP. Experimental approach: Ho/UiO-66 was synthesized via a solvothermal method and characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, Raman spectroscopy, nitrogen adsorption-desorption analysis, scanning electron microscopy, transmission electron microscopy and energy-dispersive X-ray mapping. The electrochemical behaviour of ACE and CIP at the Ho/UiO-66-modified glassy carbon electrode (Ho/UiO-66/GCE) was investigated using cyclic voltammetry and differential pulse voltammetry. The effects of solution pH, scan rate, accumulation potential, and accumulation time were systematically optimized. Key results: The characterization results demonstrated the successful incorporation of Ho species while preserving the crystalline structure of UiO-66. Among the investigated materials, Ho/UiO-66 (3/100 molar ratio) exhibited the most favourable combination of crystallinity, porosity and electrochemical performance, and was therefore selected for sensor fabrication. Under the optimized conditions, well-resolved oxidation peaks for ACE and CIP were obtained, enabling their simultaneous determination without mutual interference. The oxidation processes were found to be predominantly diffusion-controlled. The developed sensor exhibited satisfactory analytical performance with wide linear concentration ranges, low detection limits, satisfactory repeatability, reproducibility, and long-term stability. The sensor was applied to the determination of ACE and CIP in real pharmaceutical samples with satisfactory recoveries. The analytical results showed good agreement with those obtained using the reference high-performance liquid chromatography method. Conclusion: The proposed Ho/UiO-66/GCE sensor provides a reliable and practical platform for the simultaneous electrochemical determination of ACE and CIP, demonstrating its potential applicability for pharmaceutical analysis.
- Open Access
- 25 February 2026
- Published by International Association of Physical Chemists (IAPC) in Journal of Electrochemical Science and Engineering
- Vol. 16, 3213
Sm/UiO-66 Modified Electrode for the Electrochemical Determination of Ethambutol Hydrochloride in Pharmaceutical Formulations and Human Urine
And used as an electrode modifier for detecting ethambutol hydrochloride. The material was characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, electrochemical impedance spectroscopy, energy-dispersive X-ray mapping, X-ray photoelectron spectroscopy and scanning electron microscopy. The electrochemical behaviour of ethambutol at the Sm/UiO-66 modified glassy carbon electrode was examined using cyclic voltammetry and differential pulse voltammetry. The Sm/UiO-66-modified electrode exhibited a strong electrocatalytic response toward ethambutol oxidation, with a clearly defined anodic peak current. Under optimized conditions, the sensor showed a linear response in the 0.5 to 9.9 µM concentration range with a detection limit of 0.23 µM. The sensor demonstrated excellent repeatability (RSD < 3.5 %, n = 10), stability over one week, and high selectivity against common interfering substances. Notably, the proposed method was successfully applied to determine ethambutol in three pharmaceutical and three human urine samples, with exceptional recoveries. The proposed Sm/UiO-66 modified electrode is a reliable, sensitive, and selective tool for ethambutol analysis. This method can serve as a practical alternative or complementary approach for routine pharmaceutical quality control and therapeutic monitoring in tuberculosis treatment.
- 25 February 2026
- Published by International Association of Physical Chemists (IAPC) in Journal of Electrochemical Science and Engineering
- Vol. 16, 3213
Open AccessSm/UiO-66 Modified Electrode for the Electrochemical Determination of Ethambutol Hydrochloride in Pharmaceutical Formulations and Human Urine
And used as an electrode modifier for detecting ethambutol hydrochloride. The material was characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, electrochemical impedance spectroscopy, energy-dispersive X-ray mapping, X-ray photoelectron spectroscopy and scanning electron microscopy. The electrochemical behaviour of ethambutol at the Sm/UiO-66 modified glassy carbon electrode was examined using cyclic voltammetry and differential pulse voltammetry. The Sm/UiO-66-modified electrode exhibited a strong electrocatalytic response toward ethambutol oxidation, with a clearly defined anodic peak current. Under optimized conditions, the sensor showed a linear response in the 0.5 to 9.9 µM concentration range with a detection limit of 0.23 µM. The sensor demonstrated excellent repeatability (RSD < 3.5 %, n = 10), stability over one week, and high selectivity against common interfering substances. Notably, the proposed method was successfully applied to determine ethambutol in three pharmaceutical and three human urine samples, with exceptional recoveries. The proposed Sm/UiO-66 modified electrode is a reliable, sensitive, and selective tool for ethambutol analysis. This method can serve as a practical alternative or complementary approach for routine pharmaceutical quality control and therapeutic monitoring in tuberculosis treatment.
- Open Access
- 23 February 2026
- Published by International Association of Physical Chemists (IAPC) in Journal of Electrochemical Science and Engineering
- Vol. 16, 3001
Determination of acetaminophen and theophylline in drug samples by electrochemical method using Fe/MCM-41 modified electrode
In this study, we developed an electrochemical sensor based on an Fe/MCM-41 modified electrode for the simultaneous analysis of acetaminophen (AT) and theophylline (TP). The Fe/MCM-41 material was produced from diatomite silica and ferric chloride salts via a hydrothermal method. The synthesized material was characterized by XRD, SEM, TEM, EDX mapping, and nitrogen adsorption-desorption isotherms. Results showed that the Fe/MCM-41 maintained its mesoporous structure, high surface area, and uniform dispersion of Fe ions. Electrochemical tests revealed that the Fe/MCM-41 electrode exhibits superior electrocatalytic activity and higher current responses for both analytes than the bare electrode. The two oxidation peaks of AT and TP were distinctly separated, enabling simultaneous quantification of drugs with high selectivity. The peak current increased linearly with AT and TP concentrations from 0.50 to 14.15 µM, with detection limits of 0.430 and 0.350 µM, respectively. Notably, the sensor was successfully used to analyze pharmaceutical formulations containing one or both active substances, with satisfactory recoveries. The results confirm that the Fe/MCM-41 electrode is a promising sensing platform for the simultaneous analysis of AT and TP, opening new possibilities for pharmaceutical testing.
- 23 February 2026
- Published by International Association of Physical Chemists (IAPC) in Journal of Electrochemical Science and Engineering
- Vol. 16, 3001
Open AccessDetermination of acetaminophen and theophylline in drug samples by electrochemical method using Fe/MCM-41 modified electrode
In this study, we developed an electrochemical sensor based on an Fe/MCM-41 modified electrode for the simultaneous analysis of acetaminophen (AT) and theophylline (TP). The Fe/MCM-41 material was produced from diatomite silica and ferric chloride salts via a hydrothermal method. The synthesized material was characterized by XRD, SEM, TEM, EDX mapping, and nitrogen adsorption-desorption isotherms. Results showed that the Fe/MCM-41 maintained its mesoporous structure, high surface area, and uniform dispersion of Fe ions. Electrochemical tests revealed that the Fe/MCM-41 electrode exhibits superior electrocatalytic activity and higher current responses for both analytes than the bare electrode. The two oxidation peaks of AT and TP were distinctly separated, enabling simultaneous quantification of drugs with high selectivity. The peak current increased linearly with AT and TP concentrations from 0.50 to 14.15 µM, with detection limits of 0.430 and 0.350 µM, respectively. Notably, the sensor was successfully used to analyze pharmaceutical formulations containing one or both active substances, with satisfactory recoveries. The results confirm that the Fe/MCM-41 electrode is a promising sensing platform for the simultaneous analysis of AT and TP, opening new possibilities for pharmaceutical testing.
- 15 September 2020
- Published by ACG Publications in Records of Natural Products
- Vol. 15 (1) , 59-64
Chemical Constituents of Gymnosporia stylosa and Their Anti-inflammatory Activity
A new flavanone glycoside, gymnosporioside (1), and three known compounds (2-4) were isolated from the leaves of Gymnosporia stylosa. The structure of gymnosporioside (1) was determined by nuclear magnetic resonance (NMR), time-of-flight mass spectrometry (TOFMS), and circular dichroism (CD) spectral data. The known compounds were identified as prunin (2), acteoside (3), and isoacteoside (4), by comparing the NMR data from this study with those reported in the literature. These known compounds, 2-4, have not been previously isolated from G. stylosa. Their anti-inflammatory activities were evaluated against lipopolysaccharides (LPS)-induced activation of nitric oxide (NO) production in RAW264.7 cells, in vitro. Compounds 3 and 4 showed significant inhibitory activities against LPS-induced NO production in RAW264.7 cells, with IC50 values of 17.8 ± 0.4 and 19.3 ± 0.3 mM, respectively.
- 15 September 2020
- Published by ACG Publications in Records of Natural Products
- Vol. 15 (1) , 59-64
Chemical Constituents of Gymnosporia stylosa and Their Anti-inflammatory Activity
A new flavanone glycoside, gymnosporioside (1), and three known compounds (2-4) were isolated from the leaves of Gymnosporia stylosa. The structure of gymnosporioside (1) was determined by nuclear magnetic resonance (NMR), time-of-flight mass spectrometry (TOFMS), and circular dichroism (CD) spectral data. The known compounds were identified as prunin (2), acteoside (3), and isoacteoside (4), by comparing the NMR data from this study with those reported in the literature. These known compounds, 2-4, have not been previously isolated from G. stylosa. Their anti-inflammatory activities were evaluated against lipopolysaccharides (LPS)-induced activation of nitric oxide (NO) production in RAW264.7 cells, in vitro. Compounds 3 and 4 showed significant inhibitory activities against LPS-induced NO production in RAW264.7 cells, with IC50 values of 17.8 ± 0.4 and 19.3 ± 0.3 mM, respectively.